跳至主要内容
临床试验/NCT00977314
NCT00977314已完成不适用

Bone Conduction Auditory Performance Via the Tooth for Single-Sided Deafness

Sonitus Medical Inc4 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2009年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
4
主要终点
Incidence of Device- and Procedure-related Adverse Events at 30 Days

研究概览

简要总结

The purpose of this study is to determine the safety and efficacy of using bone conduction via the teeth to treat Single-Sided Deafness (SSD).

详细描述

The Sonitus Bone Conduction Device (BCD) is a bone conduction device for single-sided deafness (SSD). The Sonitus BCD consists of an Oral Appliance (OA), an external microphone component, worn behind the ear (BTE), a calibration interface cable and a PC-controlled calibration software for subject calibration. The Sonitus BCD picks up sounds from a microphone located within the ear canal of the deaf ear, capitalizing on the acoustics of the natural pinna and ear canal. The signal picked up by the microphone is then transmitted wirelessly to a removeable bone conduction oral appliance located on the upper molars. The oral appliance receives the acoustic signal from the BTE and applies an equivalent vibratory signal to the teeth that reaches the skull via bone conduction and routed transcranially to the contralateral cochlea.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must be >18, < 80 years old
  • Must be fluent in English, as determined by the PI
  • Must not be a member of a vulnerable group (IRB defined)
  • Must remain in geographic area during duration of the study
  • Diagnosis of acquired SSD (Section 3.1), time since onset (≥3 mos)
  • Must have a minimum of 6 posterior teeth remaining in the upper arch (3 teeth per side),third molars are acceptable if healthy, fully erupted and substituting for second molars

排除标准

  • Must not be current users of devices such as Baha, CROS or TransEar
  • Must not have known active medical causes of SSD:
  • Active middle ear pathology
  • Conductive HL (Otosclerosis, otitis media, otitis externa and others)
  • Sudden hearing loss that is not stable
  • Must not have known medical problems that might be life-threatening or is a contraindication for elective dental or medical procedures
  • Must not have known problems that may interfere with the impression procedure, such as inability to breath through nose (e.g. severe flu, allergies or cold)
  • Must not have allergies to polymers
  • Must not have known dental abnormalities:
  • Temporary crowns or undergoing dental treatment
  • Poor oral hygiene and/or rampant decay
  • Current orthodontics
  • Active caries in one or more of the possible abutment teeth for the device
  • Active moderate to severe periodontal disease around abutment teeth for the device
  • Suspicious oral/facial lesions or swelling of any type
  • Severe pain on palpation on any area of mouth, face or neck
  • Moderate to severe heat sensitivity on any of the upper teeth
  • Subject currently being treated for temporomandibular joint disorder (TMJ), pain, full mouth reconstruction or posterior dental implants
  • Must not have known Audiological conditions:
  • Conductive hearing loss (air-bone gap >10dB HL at more than 3 frequencies)
  • Word recognition scores inconsistent with pure tone averages
  • Fluctuating hearing loss
  • Must not have known psychological factors that interfere with their ability to comply, comprehend, consent and cooperate

结局指标

主要结局

Incidence of Device- and Procedure-related Adverse Events at 30 Days

时间窗: 30 days

The safety parameters for the trial were monitored throughout the Evaluation Phase (30 days). The safety checks included: Comprehensive Medical evaluation at Enrollment and at Termination Comprehensive Dental evaluation at Enrollment and at Termination, with interim dental checks at each visit in between, if needed Comprehensive Audiological evaluation at Enrollment and Termination.

Efficacy: Ability to Understand Speech in Noise

时间窗: Day 1, Day 30

The primary efficacy outcome was a measure of the ability to understand speech in noise while wearing the device compared with not wearing the device. The Hearing in Noise Test (HINT) was utilized for this measure as it is the most widely used test for SSD devices. An improvement in HINT score is indicated as a negative (-) dB value change. A more negative (-dB) value indicates an improvement in understanding speech in noise. An improvement in a HINT score of -1 dB is equivalent to a 10% improvement in the ability to understand speech in noise and is likely of clinical benefit. The scores are calculated as HINT Advantage (aided compared with unaided) which depict the differences of using a device as compared to not wearing a device.

次要结局

  • Measure of Benefit of SoundBite Using Abbreviated Profile of Hearing Aid Benefit (APHAB).(30 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验